Showing results (381-390 of 429) with videos related to

Sort By:
Pageof 43
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2018
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosisXavier Montalban, Ralf Gold, Alan J Thompson, et al.
Nature Immunology|January 20, 2015
Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivoAlexander Ulges, Matthias Klein, Sebastian Reuter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 29, 2025
Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosisTjalf Ziemssen, Mark S Freedman, Amit Bar-Or, et al.
Ebiomedicine|August 1, 2025
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysisBrian C Zhang, Tilman Schneider-Hohendorf, Rebecca Elyanow, et al.
Molecular Psychiatry|May 28, 2024
Altered cortical synaptic lipid signaling leads to intermediate phenotypes of mental disordersOliver Tüscher, Muthuraman Muthuraman, Johann-Philipp Horstmann, et al.
Medcomm|November 7, 2025
Neurofilament Light Chains in Serum Predict Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic EncephalopathyChristian Labenz, Eva Maria Schleicher, Myriam Meineck, et al.
Pain|March 21, 2020
Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort studyHenrik Heitmann, Bernhard Haller, Laura Tiemann, et al.
Brain : a Journal of Neurology|April 1, 2010
Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitisIngo Kleiter, Jian Song, Dominika Lukas, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2013
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitisTobias V Lanz, Simon Becker, Matthias Osswald, et al.
Biological Chemistry|February 12, 2023
Validation of TREK1 ion channel activators as an immunomodulatory and neuroprotective strategy in neuroinflammationChristina B Schroeter, Christopher Nelke, Marcus Schewe, et al.
Pageof 43